Algorithm for a short course of finasteride in patients with benign prostatic hyperplasia before transurethral resection of the prostate
https://doi.org/10.21518/2079-701X-2014-19-72-75
Abstract
Benign prostatic hyperplasia (BPH), for a long time known as benign prostatic hypertrophy, is so widespread that many researchers say, it inevitably occurs in men who have lived long enough for BPH to develop. BPH is one of the most common diseases in males from the age of 40-50 years. Histological study reveals hyperplasia in more than 60% of 60-year-old patients, and it is clinically manifested in more than 40% of men of this age group [1]. About 20% of men after the age of 60 note a significant deterioration in the quality of life due to urination disorder. Benign prostatic hyperplasia is characterized by a broad variety of symptoms.
About the Authors
KB Kolontarev
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Russia’s Ministry of Health
Russian Federation
Russian Federation
GR Kasyan
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Russia’s Ministry of Health
Russian Federation
Russian Federation
References
1. Lepor H. Pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. Rev in Urol, 2004, 6 (Suppl. 9): 310.
2. EAU Guidelines, 2009 update.
3. Reich O, Gratzke C, Bachmann A et al. Urology Section of the Bavarian Working Group for Quality Assurance. Morbidity, mortality and early outcome of transurethral resection of the prostate: A prospective multicenter evaluation of 10,654 patients. J Urol, 2008,180(1): 246-249.
4. Foley SJ and Bailey DM. Microvessel density in prostatic hyperplasia. BJUInt, 2000, 85: 70.
Review
For citations:
Kolontarev K, Kasyan G. Algorithm for a short course of finasteride in patients with benign prostatic hyperplasia before transurethral resection of the prostate. Meditsinskiy sovet = Medical Council. 2014;(19):72-75. (In Russ.) https://doi.org/10.21518/2079-701X-2014-19-72-75
Views:
371
Email this article 